Peter Reinemer
Directeur Général chez Opterion Health AG
Profil
Peter Reinemer is currently the Chief Executive Officer at Opterion Health AG since 2021.
He previously worked as the Director of Business Development & Biology at InterMed Discovery GmbH in 2011-2012, a Principal at Bayer HealthCare AG, Bayer CropScience AG, and Senior Scientist at Bayer HealthCare Pharmaceuticals, Inc. He also served as the Chief Operating Officer and Executive Vice President at Proteros biostructures GmbH.
Reinemer earned his doctorate degree from Max-Planck-Institute for Molecular Genetics in 1992.
Postes actifs de Peter Reinemer
| Sociétés | Poste | Début |
|---|---|---|
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Directeur Général | 01/02/2023 |
Anciens postes connus de Peter Reinemer
| Sociétés | Poste | Fin |
|---|---|---|
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Directeur des opérations | 06/12/2017 |
InterMed Discovery GmbH
 InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Corporate Officer/Principal | 21/08/2012 |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Directeur Technique/Scientifique/R&D | 01/01/1998 |
Bayer CropScience AG
 Bayer CropScience AG Chemicals: AgriculturalProcess Industries Bayer CropScience AG manufactures and distributes pesticides, and vegetable seeds. Its products include crops such as cotton, fruits and vegetables, oil seeds and wheat, brands includes fungicides, herbicides and seeds growth. The company was founded in 1979 and is headquartered In Monheim am Rhein, Germany. | Corporate Officer/Principal | 01/01/1994 |
Bayer HealthCare AG
 Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Corporate Officer/Principal | - |
Formation de Peter Reinemer
| Max-Planck-Institute for Molecular Genetics | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Bayer CropScience AG
Bayer CropScience AG Chemicals: AgriculturalProcess Industries Bayer CropScience AG manufactures and distributes pesticides, and vegetable seeds. Its products include crops such as cotton, fruits and vegetables, oil seeds and wheat, brands includes fungicides, herbicides and seeds growth. The company was founded in 1979 and is headquartered In Monheim am Rhein, Germany. | Process Industries |
InterMed Discovery GmbH
InterMed Discovery GmbH Miscellaneous Commercial ServicesCommercial Services InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales. | Commercial Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
Opterion Health AG
Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Health Services |
